Medical Cannabis News

Americans For Safe Access: “2022 State of the States Report: An Analysis of Medical Cannabis Access in the United States.

Published

on


They write

Today, we are excited to unveil our annual report, “2022 State of the States Report: An Analysis of Medical Cannabis Access in the United States.”The report evaluates the effectiveness of each state cannabis program from a patient perspective and assigns a grade using a rubric that reflects the key issues affecting patient access, broken down into more than 100 categories, including: barriers to access, civil protections, affordability, health and social equity, and product safety. The report also assigns penalties for harmful policies. ASA distributes the report to state legislators and regulators in every state, as well as hundreds of health and patient organization across the country.

Despite an increase in registered patient numbers and states with medical cannabis programs, the report highlights the fact that states are still falling short in creating programs that fulfill the needs of all patients– the average grade among states was only 46.16% with Maryland earning the highest score of 75.71%. The report also highlights new issues facing patients including a decline in legislative improvements to state medical cannabis programs and the negative impacts recreational adult-use laws are having on medical cannabis access.

The report also offers solutions to improve state programs including legislative and regulatory language. Since the first edition in 2014, advocates and state legislators have utilized our report to pass new legislation and regulations to improve medical cannabis access. This year’s report offers policymakers a Medical Cannabis Equity Checklist with legislative improvements for states with recreational adult-use programs or those considering adopting such programs, to ensure patient access is not harmed.

We recognizes that state policymakers and regulators have been tasked with creating the infrastructure for a supply chain that remains illegal at the federal level and are now addressing a new health concern of the seemingly federally legal, unregulated cannabinoid market. In 2022 alone, 99 pieces of legislation were introduced regarding the unregulated cannabinoid market. The State of the States report calls on state legislatures to join patient advocates in calling on Congress to pass comprehensive federal legislation, and offers steps to do so in the “State’s Government’s Role in Ending Federal Prohibition” section.

Ultimately, we create this report for our dedicated advocates and we hope this report is useful to anyone who seeks to improve medical cannabis access in their state or territory.

We will be reaching out soon with more information on how you can effectively use this report with your lawmakers and regulators so keep an eye out and take some time to review the report.

 

Review a PDF copy of the report

Watch us discuss the report at our editorial briefing



Source link

Trending

Exit mobile version